factorxiiipro.com domain details, Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | novoMEDLINK™
Description: Tretten® is the only recombinant therapy approved for congenital FXIII A-subunit deficiency, a very rare autosomal recessive bleeding disorder. Read Important Safety and Prescribing Info.
Domain rank: 100000000
Domain speed: Slow (0.320 seconds at 0.331 MB/s)
Indexed URLs from factorxiiipro.com website (11)
The links in column here only counts links from external domains.
found date
links in
url title
url
2022-07-08
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | novoMEDLINK™
2022-07-08
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | novoMEDLINK™
2022-07-08
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | novoMEDLINK™
2022-07-08
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | novoMEDLINK™
2022-07-08
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | novoMEDLINK™
2022-08-03
2022-07-08
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | novoMEDLINK™
2022-07-08
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | novoMEDLINK™
2022-07-08
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | novoMEDLINK™
2022-08-03
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | novoMEDLINK™
2022-07-08
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | novoMEDLINK™